Qiu Li

780 total citations
39 papers, 408 citations indexed

About

Qiu Li is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Qiu Li has authored 39 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Qiu Li's work include Virus-based gene therapy research (4 papers), CAR-T cell therapy research (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Qiu Li is often cited by papers focused on Virus-based gene therapy research (4 papers), CAR-T cell therapy research (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Qiu Li collaborates with scholars based in China, United States and Australia. Qiu Li's co-authors include Tingyu Li, Pengfei Zhang, Ting Yang, Xi Lai, Jie Yang, Jiang Zhu, Jie Chen, Min Guo, Dan Xie and Jie Chen and has published in prestigious journals such as Journal of Clinical Oncology, Cell Death and Differentiation and Frontiers in Immunology.

In The Last Decade

Qiu Li

37 papers receiving 404 citations

Peers

Qiu Li
Bingkun Li China
Yanxun Han China
Brett Klamer United States
Hsiu‐Huei Peng Taiwan
Letha E. Mills United States
Jeong‐Eun Kim South Korea
M. Schrader Germany
Takehiko Tarui Japan
Yichen Zhu China
Bingkun Li China
Qiu Li
Citations per year, relative to Qiu Li Qiu Li (= 1×) peers Bingkun Li

Countries citing papers authored by Qiu Li

Since Specialization
Citations

This map shows the geographic impact of Qiu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiu Li more than expected).

Fields of papers citing papers by Qiu Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiu Li. The network helps show where Qiu Li may publish in the future.

Co-authorship network of co-authors of Qiu Li

This figure shows the co-authorship network connecting the top 25 collaborators of Qiu Li. A scholar is included among the top collaborators of Qiu Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiu Li. Qiu Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Huang, Peng, et al.. (2024). Neoantigens in cancer immunotherapy: focusing on alternative splicing. Frontiers in Immunology. 15. 1437774–1437774. 18 indexed citations
3.
Liao, Wei‐Ting, Qiuji Wu, Yang Yang, et al.. (2024). Cost-effectiveness analysis of durvalumab plus tremelimumab as first-line therapy in patients with unresectable hepatocellular carcinoma. Therapeutic Advances in Medical Oncology. 16. 12719361–12719361.
4.
Zhang, Pengfei, et al.. (2024). Exploring Molecular Mechanisms in the Second-Line Treatment of Biliary Tract Malignant Tumors. Discovery Medicine. 36(180). 48–48. 1 indexed citations
5.
Wang, Yuhan, et al.. (2023). Ubiquitin-specific peptidase 1: assessing its role in cancer therapy. Clinical and Experimental Medicine. 23(7). 2953–2966. 16 indexed citations
6.
Wu, Jiayu, et al.. (2023). Case series and literature review of primary hyperoxaluria type 1 in Chinese patients. Urolithiasis. 51(1). 123–123. 5 indexed citations
7.
Jiang, Wei, Chun Loo Gan, Qing Yang, et al.. (2023). Klotho inhibits renal ox-LDL deposition via IGF-1R/RAC1/OLR1 signaling to ameliorate podocyte injury in diabetic kidney disease. Cardiovascular Diabetology. 22(1). 293–293. 16 indexed citations
8.
Liao, Wei‐Ting, et al.. (2022). Study on the prognosis, immune and drug resistance of m6A-related genes in lung cancer. BMC Bioinformatics. 23(1). 437–437. 11 indexed citations
9.
Zhu, Jiang, Ting Yang, Min Guo, et al.. (2021). Alterations in Gut Vitamin and Amino Acid Metabolism are Associated with Symptoms and Neurodevelopment in Children with Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. 52(7). 3116–3128. 29 indexed citations
10.
Xie, Dan, et al.. (2021). Adding Enzalutamide to First-Line Treatment for Metastatic Hormone-Sensitive Prostate Cancer: A Cost-Effectiveness Analysis. Frontiers in Public Health. 9. 608375–608375. 9 indexed citations
11.
Lai, Xi, Jiang Zhu, Ting Yang, et al.. (2020). A weekly vitamin A supplementary program alleviates social impairment in Chinese children with autism spectrum disorders and vitamin A deficiency. European Journal of Clinical Nutrition. 75(7). 1118–1125. 23 indexed citations
12.
Yang, Ting, Jieping Zhu, Qiu Li, et al.. (2019). Maternal folic acid and micronutrient supplementation is associated with vitamin levels and symptoms in children with autism spectrum disorders. Reproductive Toxicology. 91. 109–115. 43 indexed citations
13.
Liu, Lu, Qiu Li, Zhongshang Yuan, et al.. (2018). Non‐high‐density lipoprotein cholesterol is more informative than traditional cholesterol indices in predicting diabetes risk for women with normal glucose tolerance. Journal of Diabetes Investigation. 9(6). 1304–1311. 9 indexed citations
14.
Yang, Baohui, Xiao Xiong, Gaofu Zhang, et al.. (2016). Effect of CD40/CD40L signaling on IL-10-producing regulatory B cells in Chinese children with Henoch-Schönlein purpura nephritis. Immunologic Research. 65(3). 592–604. 22 indexed citations
15.
Zhou, Yi, et al.. (2015). Vesicular stomatitis virus is a potent agent for the treatment of malignant ascites. Oncology Reports. 35(3). 1573–1581. 10 indexed citations
16.
Song, Fangfang, Qiu Li, Yawen Zhao, et al.. (2015). A functional genetic variant in fragile-site gene FATS modulates the risk of breast cancer in triparous women. BMC Cancer. 15(1). 559–559. 7 indexed citations
17.
18.
Zeng, Dequan, Shengtao Zhou, Hao Hu, et al.. (2011). Proteomic Analyses of Gastric Cancer Cells Treated with Vesicular Stomatitis Virus Matrix Protein. The Protein Journal. 30(5). 308–317. 7 indexed citations
19.
Peng, Xingchen, Meng Qiu, Benxu Tan, et al.. (2011). Different combination schedules of gemcitabine with endostar affect antitumor efficacy. Cancer Chemotherapy and Pharmacology. 69(1). 239–246. 11 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bingkun Li Breakdown of academic impact, for papers by Yanxun Han Breakdown of academic impact, for papers by Brett Klamer Breakdown of academic impact, for papers by Hsiu‐Huei Peng Breakdown of academic impact, for papers by Letha E. Mills Breakdown of academic impact, for papers by Jeong‐Eun Kim Breakdown of academic impact, for papers by M. Schrader Breakdown of academic impact, for papers by Takehiko Tarui Breakdown of academic impact, for papers by Yichen Zhu
Rankless by CCL
2026